NeueHealth, Inc. financial data

Symbol
NEUE
Location
Doral, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2025 - 07 Aug 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 69% % -20%
Debt-to-equity -80% % 33%
Return On Equity 6% % -92%
Return On Assets -11% % 84%
Operating Margin -3% % 94%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9,024,240 shares 9%
Common Stock, Shares, Outstanding 9,024,240 shares 9%
Entity Public Float $22,018,509 USD -53%
Common Stock, Value, Issued $1,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 8,978,000 shares 8.8%
Weighted Average Number of Shares Outstanding, Diluted 8,978,000 shares 8.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $890,440,000 USD -14%
Selling and Marketing Expense $174,000 USD -33%
General and Administrative Expense $31,301,000 USD 74%
Operating Income (Loss) $29,841,000 USD 95%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $60,876,000 USD 89%
Income Tax Expense (Benefit) $2,211,000 USD 89%
Net Income (Loss) Attributable to Parent $81,930,000 USD 91%
Earnings Per Share, Basic -15 USD/shares 87%
Earnings Per Share, Diluted -15 USD/shares 87%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $131,618,000 USD -1.4%
Accounts Receivable, after Allowance for Credit Loss, Current $53,074,000 USD 48%
Assets, Current $639,882,000 USD -19%
Property, Plant and Equipment, Net $11,664,000 USD -3%
Operating Lease, Right-of-Use Asset $22,284,000 USD -17%
Intangible Assets, Net (Excluding Goodwill) $66,088,000 USD -13%
Other Assets, Noncurrent $26,055,000 USD 10%
Assets $743,689,000 USD -17%
Accounts Payable, Current $5,317,000 USD -38%
Liabilities, Current $908,412,000 USD -13%
Operating Lease, Liability, Noncurrent $17,583,000 USD -22%
Other Liabilities, Noncurrent $15,899,000 USD -11%
Liabilities $1,136,744,000 USD -3.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD
Retained Earnings (Accumulated Deficit) $4,464,323,000 USD -1.9%
Stockholders' Equity Attributable to Parent $1,369,201,000 USD -4.8%
Liabilities and Equity $743,689,000 USD -17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $21,049,000 USD 57%
Net Cash Provided by (Used in) Financing Activities $2,702,000 USD 99%
Net Cash Provided by (Used in) Investing Activities $63,176,000 USD -68%
Common Stock, Shares Authorized 3,000,000,000 shares 0%
Common Stock, Shares, Issued 9,024,240 shares 9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $39,425,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $212,931,000 USD -19%
Interest Paid, Excluding Capitalized Interest, Operating Activities $3,587,000 USD -50%
Deferred Tax Assets, Valuation Allowance $655,172,000 USD 34%
Deferred Tax Assets, Gross $663,192,000 USD 22%
Operating Lease, Liability $23,906,000 USD -19%
Payments to Acquire Property, Plant, and Equipment $1,026,000 USD 1503%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $81,930,000 USD 91%
Lessee, Operating Lease, Liability, to be Paid $27,523,000 USD -19%
Property, Plant and Equipment, Gross $21,909,000 USD -3.5%
Operating Lease, Liability, Current $6,323,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,179,000 USD -6.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,132,000 USD -10%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 17%
Deferred Income Tax Expense (Benefit) $0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,617,000 USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,672,000 USD -14%
Deferred Tax Assets, Operating Loss Carryforwards $492,570,000 USD 73%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,121,000 USD -13%
Additional Paid in Capital $3,107,121,000 USD 0.63%
Amortization of Intangible Assets $10,000,000 USD -15%
Depreciation, Depletion and Amortization $3,559,000 USD -22%
Deferred Tax Assets, Net of Valuation Allowance $8,020,000 USD -85%
Share-based Payment Arrangement, Expense $5,600,000 USD -70%
Interest Expense $33,346,000 USD 72%